First China Pharmaceutical Group (FCPG) Stock Price, News & Analysis

Company Overview

First China Pharmaceutical Group (OTCMKTS:FCPG) is a diversified healthcare and pharmaceutical company engaged in the research, development, manufacturing and sale of a wide range of conventional and traditional Chinese medicinal products. Founded in the early 1990s and headquartered in Hong Kong, the company operates through subsidiaries and joint ventures across mainland China, Southeast Asia and select international markets. Over the years, First China Pharmaceutical Group has established itself as a provider of both prescription pharmaceuticals and consumer health products.

The company’s core business activities include active pharmaceutical ingredient (API) production, formulation manufacturing and distribution of finished dosage forms. Its portfolio encompasses antibiotics, cardiovascular drugs, digestive aids, anti-cancer agents and immunosuppressants. In parallel, the firm maintains dedicated research and development centers focused on innovative drug delivery systems, novel small‐molecule therapeutics and the integration of modern biotech techniques with traditional herbal medicine principles.

In addition to conventional pharmaceuticals, First China Pharmaceutical Group has developed a competitive presence in the botanical and natural health sectors. Key offerings include standardized extracts of Ginkgo biloba, Ganoderma lucidum, American ginseng and other herbal materials, which are incorporated into dietary supplements, functional foods and cosmetic ingredients. The company’s manufacturing facilities comply with Good Manufacturing Practice (GMP) standards, enabling it to serve both domestic and export markets with quality assurance.

First China Pharmaceutical Group’s strategic footprint extends across Greater China, Southeast Asia and North America, supported by a network of distribution partners and licensing agreements. The leadership team comprises seasoned industry executives with backgrounds in pharmaceutical R&D, regulatory affairs and international commercialization. Through a combination of in‐house innovation and collaborative alliances, the company aims to expand its product pipeline and strengthen its position in the global pharmaceutical landscape.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 15,858 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

FCPG Stock Analysis - Frequently Asked Questions

How do I buy shares of First China Pharmaceutical Group?

Shares of FCPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of First China Pharmaceutical Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that First China Pharmaceutical Group investors own include SES AI (SES), American Heritage International (AHII), Affinity Networks (AFFN), Astera Labs (ALAB), Akoustis Technologies (AKTS) and American Battery Technology (ABAT).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Manufacturing
• Industry: Electronic Computer Manufacturing
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:FCPG
• CIK: 1432254
• Web: www.firstchinapharma.com
• Phone: +86-852-21381668
• Fax: N/A
• Employees: 147,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A